{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:38:23Z","timestamp":1791185903971,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH077681"],"award-info":[{"award-number":["MH077681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH19961"],"award-info":[{"award-number":["MH19961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH014276"],"award-info":[{"award-number":["MH014276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA033945"],"award-info":[{"award-number":["DA033945"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA14241"],"award-info":[{"award-number":["DA14241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.neuropharm.2014.12.028","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T17:21:27Z","timestamp":1420824087000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"PB","title":["Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4404-1280","authenticated-orcid":false,"given":"Marina R.","family":"Picciotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-562X","authenticated-orcid":false,"given":"Gerrit I.","family":"van Schalkwyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann S.","family":"Mineur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.12.028_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpsycho.2007.03.016","article-title":"Anger and psychobiological changes during smoking abstinence and in response to acute stress: prediction of smoking relapse","volume":"66","author":"al'Absi","year":"2007","journal-title":"Int. J. Psychophysiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1176\/appi.ajp.2010.10040569","article-title":"Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"168","author":"Allen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00403714","article-title":"Dissimilar influences of imipramine, benactyzine and promazine on effects of micro-injections of noradrenaline, acetylcholine and serotonin into the amygdala in the cat","volume":"15","author":"Allikmets","year":"1969","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/0021-843X.90.1.1","article-title":"An investigation into the observed sex difference in prevalence of unipolar depression","volume":"90","author":"Amenson","year":"1981","journal-title":"J.\u00a0Abnorm. Psychol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib5","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biopsych.2011.11.012","article-title":"Optogenetics, sex, and violence in the brain: implications for psychiatry","volume":"71","author":"Anderson","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib7","doi-asserted-by":"crossref","first-page":"e48665","DOI":"10.1371\/journal.pone.0048665","article-title":"Low dose nicotine and antagonism of beta2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice","volume":"7","author":"Anderson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0269881108091587","article-title":"Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests","volume":"23","author":"Andreasen","year":"2009","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FBP.0b013e32832c713e","article-title":"Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex","volume":"20","author":"Andreasen","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.pbb.2011.11.004","article-title":"Combined alpha7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987","volume":"100","author":"Andreasen","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuropharm.2013.04.060","article-title":"A\u00a0combined alpha7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances","volume":"73","author":"Andreasen","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/cap.2011.0056","article-title":"Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders","volume":"22","author":"Arnold","year":"2012","journal-title":"J.\u00a0Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib13","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1517\/14656560903329102","article-title":"Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders","volume":"10","author":"Bacher","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib14","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/2241035a0","article-title":"Facilitation of aggressive behaviour in rat by direct cholinergic stimulation of the hypothalamus","volume":"224","author":"Bandler","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0006-8993(70)90171-X","article-title":"Cholinergic synapses in the lateral hypothalamus for the control of predatory aggression in the rat","volume":"20","author":"Bandler","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0306-4522(81)90227-X","article-title":"Afferent projections to the preoptic area and hypothalamic regions in the rat brain","volume":"6","author":"Berk","year":"1981","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(76)90072-1","article-title":"Effects of nicotinic and muscarinic compounds on biting attack in the cat","volume":"5","author":"Berntson","year":"1976","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.bp.109.065912","article-title":"Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort","volume":"196","author":"Boden","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0749-3797(18)30295-2","article-title":"The impact of depression on smoking cessation in women","volume":"12","author":"Borrelli","year":"1996","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.63.8.907","article-title":"Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors","volume":"63","author":"Brody","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00127-002-0569-0","article-title":"The influence of age on gender differences in depression: further population-based evidence on the relationship between menopause and the sex difference in depression","volume":"37","author":"Cairney","year":"2002","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.JGP.0000235688.05709.e2","article-title":"Adjunctive transdermal nicotine reduced behavioral agitation in severe dementia","volume":"15","author":"Carmel","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrn2849","article-title":"Nicotine addiction and nicotinic receptors: lessons from genetically modified mice","volume":"11","author":"Changeux","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002130100681","article-title":"The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses","volume":"155","author":"Cheeta","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib26","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/cne.22620","article-title":"Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain","volume":"519","author":"Chen","year":"2011","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib27","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib28","first-page":"67","article-title":"Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD)","volume":"32","author":"Conners","year":"1996","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/01688638908400888","article-title":"Development of a scale for assessment of agitation following traumatic brain injury","volume":"11","author":"Corrigan","year":"1989","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib30","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1096\/fj.13-231084","article-title":"Nonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex","volume":"27","author":"Coura","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v17n01_04","article-title":"Cigarette smoking and major depression","volume":"17","author":"Covey","year":"1998","journal-title":"J.\u00a0Addict. Dis."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2012.05.009","article-title":"Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia","volume":"72","author":"D'Souza","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib34","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neuropharm.2011.01.044","article-title":"Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits","volume":"62","author":"D'Souza","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0006-3223(02)01458-0","article-title":"Neural and behavioral substrates of mood and mood regulation","volume":"52","author":"Davidson","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0920-9964(98)00045-0","article-title":"Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders","volume":"33","author":"Diwan","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-4388(00)00203-8","article-title":"Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders","volume":"11","author":"Drevets","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0091-3057(81)90240-9","article-title":"Selective inhibition by nicotine of shock-induced fighting in the rat","volume":"14","author":"Driscoll","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00406-012-0377-9","article-title":"Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls","volume":"263","author":"Drusch","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2967\/jnumed.112.111922","article-title":"Imaging changes in synaptic acetylcholine availability in living human subjects","volume":"54","author":"Esterlis","year":"2013","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","article-title":"Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment","volume":"3","author":"Fagerstrom","year":"1978","journal-title":"Addict. Behav."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2014.12.028_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1520-6394(1998)8:1+<59::AID-DA9>3.0.CO;2-Y","article-title":"Anger attacks in depression","volume":"8","author":"Fava","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib43","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1523\/JNEUROSCI.17-15-05747.1997","article-title":"Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine","volume":"17","author":"Fenster","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib44","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.19-12-04804.1999","article-title":"Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine","volume":"19","author":"Fenster","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(99)00889-4","article-title":"Neurobiological mechanisms by which nicotine mediates different types of anxiety","volume":"393","author":"File","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0091-3057(00)00198-2","article-title":"The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety","volume":"66","author":"File","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib47","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1523\/JNEUROSCI.21-22-08979.2001","article-title":"Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in\u00a0vivo microdialysis study","volume":"21","author":"Fu","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib48","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-3565(24)37341-0","article-title":"Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors","volume":"284","author":"Fu","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib49","doi-asserted-by":"crossref","first-page":"15148","DOI":"10.1523\/JNEUROSCI.0941-12.2012","article-title":"Presynaptic alpha4beta2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus","volume":"32","author":"Garduno","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J.\u00a0Clin. Psychopharm."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib51","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0191-8869(98)00003-8","article-title":"Effects of smoking abstinence on mood and craving in men: influences of negative-affect-related personality traits, habitual nicotine intake and repeated measurements","volume":"25","author":"Gilbert","year":"1998","journal-title":"Pers. Individ. Differ."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib52","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression","volume":"264","author":"Glassman","year":"1990","journal-title":"Jama"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib53","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1471-4159.1994.62041390.x","article-title":"Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes","volume":"62","author":"Grady","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib54","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1046\/j.1460-9568.2000.00262.x","article-title":"Localization of nAChR subunit mRNAs in the brain of Macaca mulatta","volume":"12","author":"Han","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib55","first-page":"56","article-title":"Characterization of tobacco withdrawal: physiological and subjective effects","volume":"53","author":"Hatsukami","year":"1985","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/appi.ajp.2014.13111553","article-title":"Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior","volume":"171","author":"Hoptman","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/dneu.20348","article-title":"Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups","volume":"67","author":"Huang","year":"2007","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0028-3908(70)90049-3","article-title":"Changes in emotional behaviour after application of cholinesterase inhibitor in the septal and amygdala region","volume":"9","author":"Igic","year":"1970","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0024-3205(03)00289-3","article-title":"Effects of nicotine on target biting and resident-intruder attack","volume":"73","author":"Johnson","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib60","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1471-4159.2000.0752409.x","article-title":"Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release","volume":"75","author":"Kenny","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib62","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.15288\/jsad.2011.72.1019","article-title":"Vulnerability to the rapid (\u201ctelescoped\u201d) development of alcohol dependence in individuals with anxiety disorder","volume":"72","author":"Kushner","year":"2011","journal-title":"J.\u00a0Stud. Alcohol Drugs"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib63","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15288\/jsad.2012.73.920","article-title":"Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder","volume":"73","author":"Kushner","year":"2012","journal-title":"J.\u00a0Stud. Alcohol Drugs"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib64","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1073\/pnas.041582598","article-title":"Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety","volume":"98","author":"Labarca","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib65","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11920-001-0040-z","article-title":"Depression and nicotine: preclinical and clinical evidence for common mechanisms","volume":"3","author":"Laje","year":"2001","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1025048802629","article-title":"The emotional brain, fear, and the amygdala","volume":"23","author":"LeDoux","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib67","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature13169","article-title":"Scalable control of mounting and attack by Esr1+ neurons in the ventromedial hypothalamus","volume":"509","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib68","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.18-05-01904.1998","article-title":"Presynaptic nicotinic receptors facilitate monoaminergic transmission","volume":"18","author":"Li","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09736","article-title":"Functional identification of an aggression locus in the mouse hypothalamus","volume":"470","author":"Lin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib70","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/cc8954","article-title":"Nicotine withdrawal and agitation in ventilated critically ill patients","volume":"14","author":"Lucidarme","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(80)90277-2","article-title":"Interrelations between lateral, dorsomedial and ventromedial hypothalamic nuclei in the rat. An HRP study","volume":"190","author":"Luiten","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib72","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0896-6273(02)00625-6","article-title":"Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas","volume":"33","author":"Mansvelder","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3565(25)21452-5","article-title":"Genetics of nicotine response in four inbred strains of mice","volume":"226","author":"Marks","year":"1983","journal-title":"J.\u00a0Pharm. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib75","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0022-3565(25)25031-5","article-title":"Nicotine-induced tolerance and receptor changes in four mouse strains","volume":"237","author":"Marks","year":"1986","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0306-4530(97)00079-6","article-title":"Response of the hypothalamo-pituitary-adrenal axis to nicotine","volume":"23","author":"Matta","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib78","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1212\/WNL.57.3.551","article-title":"Delirium from nicotine withdrawal in neuro-ICU patients","volume":"57","author":"Mayer","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00213-006-0516-y","article-title":"Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial","volume":"189","author":"McClernon","year":"2006","journal-title":"Psychophamacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib80","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1523\/JNEUROSCI.0937-11.2011","article-title":"alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief","volume":"31","author":"McGranahan","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib148","series-title":"Manual for the Profile of Mood States","author":"McNair","year":"1971"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib81","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.npp.1300753","article-title":"Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men","volume":"30","author":"Mendelson","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0005-7967(94)90023-X","article-title":"Childhood depression and aggression: a covariance structure analysis","volume":"32","author":"Messer","year":"1994","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(98)00658-X","article-title":"Effects of nicotine and mecamylamine on rat dorsal raphe neurons","volume":"360","author":"Mihailescu","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib84","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib85","article-title":"Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine","author":"Mineur","year":"2014","journal-title":"Neuropsychopharmacology (advance online publication)"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FBP.0b013e328347546d","article-title":"alpha4beta2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties","volume":"22","author":"Mineur","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib87","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1073\/pnas.1219731110","article-title":"Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior","volume":"110","author":"Mineur","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib88","first-page":"1","article-title":"Biological basis for the co-morbidity between smoking and mood disorders","volume":"5","author":"Mineur","year":"2009","journal-title":"J.\u00a0Dual Diagn."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib89","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib90","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00213-013-3178-6","article-title":"Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet","volume":"230","author":"Morganstern","year":"2013","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.133.2.245","article-title":"Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships","volume":"133","author":"Morissette","year":"2007","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1741-7015-10-123","article-title":"Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies","volume":"10","author":"Moylan","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nrn2174","article-title":"Neural mechanisms of aggression","volume":"8","author":"Nelson","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib95","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jamapsychiatry.2013.4291","article-title":"Epigenetic mechanisms of depression","volume":"71","author":"Nestler","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib96","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The mesolimbic dopamine reward circuit in depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/npp.1994.11","article-title":"Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior","volume":"10","author":"Newhouse","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib98","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1037\/0893-164X.15.2.133","article-title":"Effects of nicotine deprivation and irritability on physical aggression in male smokers","volume":"15","author":"Parrott","year":"2001","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2826.2008.01701.x","article-title":"Biology of post-traumatic stress disorder in childhood and adolescence","volume":"20","author":"Pervanidou","year":"2008","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib101","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4088\/JCP.08m04441","article-title":"Varenicline augmentation in depressed smokers: an 8-week, open-label study","volume":"70","author":"Philip","year":"2009","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","article-title":"It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood","volume":"84","author":"Picciotto","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib103","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib104","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib105","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1152\/jn.01030.2012","article-title":"alpha7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability","volume":"110","author":"Pidoplichko","year":"2013","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib106","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2013.08.009","article-title":"The beta4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion","volume":"555","author":"Radhakrishnan","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib107","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/00001756-200410050-00030","article-title":"Nicotine infusion into rat ventromedial nuclei and effects on monoaminergic system","volume":"15","author":"Ramos","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib108","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/1098-2337(2000)26:5<376::AID-AB3>3.0.CO;2-5","article-title":"Effects of acute administration of nicotine and lobeline on agonistic encounters in male mice","volume":"26","author":"Redolat","year":"2000","journal-title":"Aggress. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib109","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.7433977","article-title":"Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol","volume":"209","author":"Risch","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00431996","article-title":"Effects of nicotine, mecamylamine, and hexamethonium on shock-induced fighting, pain reactivity, and locomotor behaviour in rats","volume":"66","author":"Rodgers","year":"1979","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib111","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0306-4522(94)90302-6","article-title":"Efferent connections of the hypothalamic \u201caggression area\u201d in the rat","volume":"59","author":"Roeling","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib112","first-page":"569","article-title":"The importance of central nicotinic receptors in footshock-induced aggression in mice","volume":"33","author":"Rolinski","year":"1981","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib113","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib114","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2009.01.002","article-title":"Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect","volume":"605","author":"Rollema","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00019442-200111000-00014","article-title":"Transdermal nicotine for agitation in dementia","volume":"9","author":"Rosin","year":"2001","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib116","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02246496","article-title":"Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients","volume":"121","author":"Salin-Pascual","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib117","first-page":"387","article-title":"Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression","volume":"57","author":"Salin-Pascual","year":"1996","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib118","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib119","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1176\/appi.ajp.2012.11101546","article-title":"Persistent beta2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder","volume":"169","author":"Saricicek","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1176\/appi.ajp.2010.10111680","article-title":"Nicotine replacement therapy in the psychiatric emergency department","volume":"168","author":"Schechter","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib121","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0014-2999(74)90032-6","article-title":"Effect of nicotine on response to frustrative non-reward in the rat","volume":"29","author":"Schechter","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib122","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0091-3057(01)00715-8","article-title":"Nicotinic\u2013serotonergic interactions in brain and behaviour","volume":"71","author":"Seth","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib123","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0149-7634(98)00040-2","article-title":"Neuropharmacology of brain-stimulation-evoked aggression","volume":"23","author":"Siegel","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2000.10.59","article-title":"Mecamylamine in Tourette's syndrome: a two-year retrospective case study","volume":"10","author":"Silver","year":"2000","journal-title":"J.\u00a0Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib127","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J.\u00a0Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0003-3472(71)80136-7","article-title":"Behaviour of rats given a \u201csmoking dose\u201d of nicotine","volume":"19","author":"Silverman","year":"1971","journal-title":"Anim. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib129","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1192\/bjp.147.2.127","article-title":"Irritability: definition, assessment and associated factors","volume":"147","author":"Snaith","year":"1985","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.conb.2013.02.013","article-title":"Unraveling the neurobiology of nicotine dependence using genetically engineered mice","volume":"23","author":"Stoker","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.neuropharm.2014.12.028_bib132","first-page":"26","article-title":"Neuroreceptor mechanisms of aggression and its treatment","volume":"64","author":"Swann","year":"2003","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib133","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/7854_2011_191","article-title":"Behavioral and Pharmacogenetics of aggressive behavior","volume":"12","author":"Takahashi","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-012-2654-8","article-title":"Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus","volume":"224","author":"Takahashi","year":"2012","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0091-3057(00)00236-7","article-title":"Depressive characteristics of FSL rats: involvement of central nicotinic receptors","volume":"66","author":"Tizabi","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2014.12.028_bib137","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/mp.2012.83","article-title":"Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement","volume":"18","author":"Tolu","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib138","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuroscience.2003.09.028","article-title":"Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain","volume":"124","author":"Tribollet","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2014.12.028_bib139","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.euroneuro.2013.12.008","article-title":"Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant","volume":"24","author":"Vieta","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(80)90198-7","article-title":"Suppressive effects of intraperitoneal and intraventricular injections of nicotine on muricide and shock-induced attack on conspecifics","volume":"12","author":"Waldbillig","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib141","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0306-4603(96)00063-9","article-title":"Gender differences in the outcome of an unaided smoking cessation attempt","volume":"22","author":"Ward","year":"1997","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib142","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1073\/pnas.1209293109","article-title":"Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior","volume":"109","author":"Warner-Schmidt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib143","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14622200050011277","article-title":"Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal","volume":"2","author":"Watkins","year":"2000","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib144","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02168081","article-title":"Specificity of the comorbidity of aggression and depression in children","volume":"22","author":"Weiss","year":"1994","journal-title":"J.\u00a0Abnorm. Child Psychol."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib145","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1523\/JNEUROSCI.14-03-01623.1994","article-title":"Neuronal activity within the nucleus basalis and conditioned neocortical electroencephalographic activation","volume":"14","author":"Whalen","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib146","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-380858-5.00005-8","article-title":"The neurochemistry of human aggression","volume":"75","author":"Yanowitch","year":"2011","journal-title":"Adv. Genet."},{"key":"10.1016\/j.neuropharm.2014.12.028_bib147","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0091-3057(84)90001-7","article-title":"The effects of intrahypothalamic hemicholinium-3 on muricide, irritability and feeding","volume":"20","author":"Yoburn","year":"1984","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:32:43Z","timestamp":1747413163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814004791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":148,"alternative-id":["S0028390814004791"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.028","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}